Docetaxel population pharmacokinetic modelling and simulation in Chinese cancer patients

BACKGROUND: Docetaxel is a widely prescribed cytotoxic chemotherapy drug for various cancers and the main dose-limiting toxicity is dose-dependent neutropenia. In China, the current dose regimen for docetaxel frequently results in high inter-individual pharmacokinetic (PK) variability. There is a ve...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Jian, Zhang, Yuwen, Li, Ze, Li, Xingang, Zhao, Chenglong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279759/
https://www.ncbi.nlm.nih.gov/pubmed/35845493
http://dx.doi.org/10.21037/atm-22-2619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279759/
https://www.ncbi.nlm.nih.gov/pubmed/35845493
http://dx.doi.org/10.21037/atm-22-2619

Ejemplares similares